Perspective Therapeutics, Inc. (CATX) stock
CATXNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.75−0.03 (-3.85%)
Close on Nov 20, 2026Market cap $86.05MP/E –Yield –
Perspective Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Perspective Therapeutics's price to sales ratio was 22.2× on Jan 31, 2025, against 10.7× a year earlier. Over the last 5 years it ranged from 2.6× to 98.7×, with a median of 6.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jan 31, 2025 | 22.2× | +2.3 |
| 2024 | Dec 31, 2024 | 20.0× | +14.7 |
| 2023 | Dec 29, 2023 | 5.3× | +2.0 |
| 2022 | Dec 30, 2022 | 3.3× | −2.1 |
| 2021 | Dec 31, 2021 | 5.4× | +2.2 |
| 2020 | Dec 31, 2020 | 3.2× | −2.0 |
| 2019 | Dec 31, 2019 | 5.2× | +2.0 |
| 2018 | Dec 31, 2018 | 3.2× | −1.3 |
| 2017 | Dec 29, 2017 | 4.5× | −2.5 |
| 2016 | Dec 30, 2016 | 7.0× | −3.8 |
| 2015 | Dec 31, 2015 | 10.7× | −8.3 |
| 2014 | Dec 31, 2014 | 19.0× | +14.8 |
| 2013 | Dec 31, 2013 | 4.3× | −1.2 |
| 2012 | Dec 31, 2012 | 5.5× | +2.1 |
| 2011 | Dec 30, 2011 | 3.4× | – |
See a number that looks wrong?